Skip to main content
Caplight Logo









Lapam Capital

Lapam Capital

Overview

Lapam Capital is a Beijing-based venture capital firm specializing in early- to mid-stage investments in the biopharmaceutical and medical device sectors in China.

Year Founded

2011

Portfolio Companies

1

Investments

Lapam Capital investments
CompanyDateStageLead
Shanghai Shengzhe Medical Technology Co., Ltd.Aug 2019Pre SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Lapam Capital based?

Lapam Capital is headquartered in Beijing, China.

When was Lapam Capital founded?

Lapam Capital was founded in 2011.

How many portfolio companies does Lapam Capital have?

Lapam Capital has 1 portfolio company in Caplight's dataset.

What are some companies in Lapam Capital's portfolio?

Portfolio companies visible on Caplight include Shanghai Shengzhe Medical Technology Co., Ltd..

What was Lapam Capital's most recent investment shown here?

Lapam Capital's most recent investment in this portfolio sample was in Shanghai Shengzhe Medical Technology Co., Ltd. in 2019.

What sectors does Lapam Capital focus on?

Lapam Capital focuses on Healthcare & Life Sciences.

What company stages does Lapam Capital focus on?

Lapam Capital typically invests at the Early stage.

Firmographic Details

HeadquartersBeijing
Year Founded2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?